These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 7702421)
21. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group. Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424 [TBL] [Abstract][Full Text] [Related]
22. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836 [TBL] [Abstract][Full Text] [Related]
23. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846 [TBL] [Abstract][Full Text] [Related]
24. Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease. Plosker GL; McTavish D Drugs Aging; 1995 Sep; 7(3):226-53. PubMed ID: 8535052 [TBL] [Abstract][Full Text] [Related]
25. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. Goldman L; Sia ST; Cook EF; Rutherford JD; Weinstein MC N Engl J Med; 1988 Jul; 319(3):152-7. PubMed ID: 2898733 [TBL] [Abstract][Full Text] [Related]
26. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Rutherford JD; Pfeffer MA; Moyé LA; Davis BR; Flaker GC; Kowey PR; Lamas GA; Miller HS; Packer M; Rouleau JL Circulation; 1994 Oct; 90(4):1731-8. PubMed ID: 7923656 [TBL] [Abstract][Full Text] [Related]
27. Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy. Mantovani LG; Belisari A; Szucs TD Pharmacol Res; 1998 May; 37(5):345-51. PubMed ID: 9642029 [TBL] [Abstract][Full Text] [Related]
28. Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study. Moyé LA; Pfeffer MA; Wun CC; Davis BR; Geltman E; Hayes D; Farnham DJ; Randall OS; Dinh H; Arnold JM Eur Heart J; 1994 May; 15 Suppl B():2-8; discussion 26-30. PubMed ID: 8076658 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis and clinical practice. Rector TS; Francis GS J Am Coll Cardiol; 1995 Oct; 26(4):920-1. PubMed ID: 7560618 [No Abstract] [Full Text] [Related]
30. The economics of TRACE. A cost-effectiveness analysis of trandolapril in postinfarction patients with left ventricular dysfunction. LePen C; Lilliu H; Keller T; Fiessinger S Pharmacoeconomics; 1998 Jul; 14(1):49-58. PubMed ID: 10182194 [TBL] [Abstract][Full Text] [Related]
31. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Pfeffer MA; Pfeffer JM; Steinberg C; Finn P Circulation; 1985 Aug; 72(2):406-12. PubMed ID: 3891136 [TBL] [Abstract][Full Text] [Related]
32. Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial. Gorkin L; Follick MJ; Geltman E; Hamm P; Sollano J; Sylvia S; Jacobson K; Jacobson MJ; Cochrane BS; Sussex B Qual Life Res; 1994 Apr; 3(2):111-9. PubMed ID: 8044157 [TBL] [Abstract][Full Text] [Related]
33. Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands. Michel BC; Al MJ; Remme WJ; Kingma JH; Kragten JA; van Nieuwenhuizen R; van Hout BA Eur Heart J; 1996 May; 17(5):731-40. PubMed ID: 8737104 [TBL] [Abstract][Full Text] [Related]
34. [The effect of captopril in the patient with acute myocardial infarction]. Tsuji H; Iwasaka T; Onoyama H; Sugiura T; Ichibangase J; Ichibangase A; Inada M Kokyu To Junkan; 1984 Aug; 32(8):835-9. PubMed ID: 6393253 [No Abstract] [Full Text] [Related]
36. Captopril following acute myocardial infarction. Howard PA Ann Pharmacother; 1992 Apr; 26(4):496-8. PubMed ID: 1576388 [No Abstract] [Full Text] [Related]
37. [Heart diseases in light of SAVE-Study. Captopril improves prognosis and symptoms of left ventricular dysfunction after myocardial infarction. 41st scientific annual meeting of the American College of Cardiology. Dallas, Texas, 12-16 April 1992]. Fortschr Med Suppl; 1992; 129():1-19. PubMed ID: 1628873 [No Abstract] [Full Text] [Related]
38. [Therapeutic recommendation in cardiac insufficiency. Initial treatment--after infarct--in kidney disease]. Pitt B Fortschr Med Suppl; 1987; 33():18-22. PubMed ID: 2887496 [No Abstract] [Full Text] [Related]
39. Effects of captopril on infarct expansion. Kumar PD Am J Cardiol; 1992 Apr; 69(9):975-6. PubMed ID: 1550032 [No Abstract] [Full Text] [Related]
40. [A median attainable therapeutic goal. Living longer and better with disease]. Cohn J Fortschr Med Suppl; 1987; 33():12-5. PubMed ID: 2887495 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]